BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28550753)

  • 1. Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer.
    Zhang R; Song X; Liang C; Yi X; Song G; Chao Y; Yang Y; Yang K; Feng L; Liu Z
    Biomaterials; 2017 Sep; 138():13-21. PubMed ID: 28550753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H
    Song X; Xu J; Liang C; Chao Y; Jin Q; Wang C; Chen M; Liu Z
    Nano Lett; 2018 Oct; 18(10):6360-6368. PubMed ID: 30247918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-drug conjugate programmed by pH-reversible linker for tumor hypoxia relief and enhanced cancer combination therapy.
    Zhang X; Feng L; Dong Z; Xin X; Yang Z; Deng D; Wagner E; Liu Z; Liu X
    Int J Pharm; 2020 May; 582():119321. PubMed ID: 32289483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced co-assembly of albumin/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy.
    Chen Q; Chen J; Liang C; Feng L; Dong Z; Song X; Song G; Liu Z
    J Control Release; 2017 Oct; 263():79-89. PubMed ID: 27840167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction-sensitive platinum (IV)-prodrug nano-sensitizer with an ultra-high drug loading for efficient chemo-radiotherapy of Pt-resistant cervical cancer in vivo.
    Luo K; Guo W; Yu Y; Xu S; Zhou M; Xiang K; Niu K; Zhu X; Zhu G; An Z; Yu Q; Gan Z
    J Control Release; 2020 Oct; 326():25-37. PubMed ID: 32531414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids.
    Kieler-Ferguson HM; Chan D; Sockolosky J; Finney L; Maxey E; Vogt S; Szoka FC
    Eur J Pharm Sci; 2017 May; 103():85-93. PubMed ID: 28263913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GE11-PDA-Pt@USPIOs nano-formulation for relief of tumor hypoxia and MRI/PAI-guided tumor radio-chemotherapy.
    Yang C; Mi X; Su H; Yang J; Gu Y; Zhang L; Sun W; Liang X; Zhang C
    Biomater Sci; 2019 Apr; 7(5):2076-2090. PubMed ID: 30860522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorocarbon nanodroplets stabilized with cisplatin-prodrug-constructed lipids enable efficient tumor oxygenation and chemo-radiotherapy of cancer.
    Yao L; Feng L; Tao D; Tao H; Zhong X; Liang C; Zhu Y; Hu B; Liu Z; Zheng Y
    Nanoscale; 2020 Jul; 12(27):14764-14774. PubMed ID: 32627775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a hypoxia-triggered and hypoxic radiosensitized liposome as a doxorubicin carrier to promote synergetic chemo-/radio-therapy for glioma.
    Liu H; Xie Y; Zhang Y; Cai Y; Li B; Mao H; Liu Y; Lu J; Zhang L; Yu R
    Biomaterials; 2017 Mar; 121():130-143. PubMed ID: 28088075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
    Datta P; Bang S; Yue Z; Beach T; Stilgenbauer M; Wang H; Bowers DJ; Kurokawa M; Xiao H; Zheng YR
    Dalton Trans; 2020 Jun; 49(24):8107-8113. PubMed ID: 32490446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
    Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
    Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma.
    Hei Y; Teng B; Zeng Z; Zhang S; Li Q; Pan J; Luo Z; Xiong C; Wei S
    Int J Nanomedicine; 2020; 15():1677-1691. PubMed ID: 32214807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iridium nanocrystals encapsulated liposomes as near-infrared light controllable nanozymes for enhanced cancer radiotherapy.
    Feng L; Dong Z; Liang C; Chen M; Tao D; Cheng L; Yang K; Liu Z
    Biomaterials; 2018 Oct; 181():81-91. PubMed ID: 30077139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.
    Xiao H; Noble GT; Stefanick JF; Qi R; Kiziltepe T; Jing X; Bilgicer B
    J Control Release; 2014 Jan; 173():11-7. PubMed ID: 24511610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
    Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma.
    Alavizadeh SH; Badiee A; Golmohammadzadeh S; Jaafari MR
    Int J Pharm; 2014 Oct; 473(1-2):326-33. PubMed ID: 25051111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
    Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
    ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Chemoradiotherapy Duo: Nano-Enabled Targeting of DNA Lesion Formation and DNA Damage Response.
    Jiang W; Li Q; Zhu Z; Wang Q; Dou J; Zhao Y; Lv W; Zhong F; Yao Y; Zhang G; Liu H; Wang Y; Wang J
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35734-35744. PubMed ID: 30255704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
    Ma R; Wang Y; Yan L; Ma L; Wang Z; Chan HC; Chiu SK; Chen X; Zhu G
    Chem Commun (Camb); 2015 May; 51(37):7859-62. PubMed ID: 25854514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.